IsoPlexis Corp.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Technology Services » Packaged Software
MSFTMicrosoft Corp. -0.43%306.920.6%$7600.79m
ADBEAdobe, Inc. -0.70%631.641.1%$1743.30m, inc. -0.90%289.721.6%$1682.21m
UBERUber Technologies, Inc. -2.24%45.990.0%$1220.91m
PLTRPalantir Technologies, Inc. -1.87%24.230.0%$1102.06m
ORCLOracle Corp. -0.51%96.571.0%$1016.39m
ZMZoom Video Communications, Inc. -0.24%275.750.0%$1004.67m
CRWDCrowdStrike Holdings, Inc. 0.28%283.150.0%$786.34m
INTUIntuit, Inc. -0.47%570.131.0%$651.19m
TWLOTwilio, Inc. 0.59%367.209.6%$589.05m
DOCUDocuSign, Inc. -0.41%271.780.0%$548.11m Holdings, Inc. -0.58%295.790.0%$529.07m
ZSZscaler, Inc. -0.13%297.640.0%$500.01m
NTESNetEase, Inc. 0.93%101.320.2%$438.65m
TEAMAtlassian Corp. Plc -0.28%409.301.9%$399.11m

Company Profile

IsoPlexis Corp. engages in the development of curative medicines and personalized therapeutics. Its single cell proteomics platform, which includes instruments, chip consumables and software, provides an end-to-end solution to reveal a more complete view of protein function at an individual cellular level. The company was founded by Sean Mackay, Rong Fan, and Kara K. Brower in March 2013 and is headquartered in Branford, CT.